Amphastar Pharmaceuticals Stock

Amphastar Pharmaceuticals Employees 2024

Amphastar Pharmaceuticals Employees

1,980

Ticker

AMPH

ISIN

US03209R1032

WKN

A11664

In 2024, Amphastar Pharmaceuticals employed 1,980 people, a 0% change from the 1,980 number of employees in the previous year.

Amphastar Pharmaceuticals Aktienanalyse

What does Amphastar Pharmaceuticals do?

Amphastar Pharmaceuticals Inc is a leading biopharmaceutical company that focuses on the development, manufacturing, and marketing of generic and innovative drugs. The company was founded in 1996 and is headquartered in Rancho Cucamonga, California. History Amphastar Pharmaceuticals has a remarkable history in the generic industry. The company was founded by Dr. Jack Y. Zhang and Dr. Zhaocheng Guo, both of whom had doctorates in pharmacy. They initially worked as scientists at other pharmaceutical companies before deciding to start their own company. The beginning was difficult as they had limited financial resources and faced tough competition in the industry. However, the company grew through acquiring smaller competitors and developing its own products. Business Model Amphastar Pharmaceuticals' business model is based on the development, manufacturing, and marketing of generic drugs that meet medical needs. The company specializes in the treatment of diseases such as diabetes, heart disease, infections, and cancer. Utilizing unused patents and collaborations plays an important role in accessing new markets. Divisions Amphastar Pharmaceuticals is divided into three divisions: Human Pharmaceuticals, Veterinary Pharmaceuticals, and API (Active Pharmaceutical Ingredients). The Human Pharmaceuticals division specializes in developing products for the treatment of diseases such as diabetes, heart disease, infections, and cancer. The Veterinary Pharmaceuticals division focuses on developing veterinary drugs for livestock and pets. The API division is responsible for manufacturing raw materials for the pharmaceutical industry. Products Amphastar Pharmaceuticals offers a wide range of products, including inhalation aids for asthma, antidepressants, antidotes for anesthetics, anesthetics, drugs for cancer therapies, as well as for the treatment of HIV infections and nervous system disorders. In the field of veterinary products, Amphastar produces antibiotics, antifungals, vitamins, and hormones for animals. Conclusion Amphastar Pharmaceuticals Inc is a successful biopharmaceutical company specializing in the development, manufacturing, and marketing of generic and innovative drugs for a wide range of diseases. Since its inception, the company has been focused on growth and has continuously evolved through acquiring smaller competitors and developing its own products. The company offers a wide range of products for use in human and veterinary medicine and places special emphasis on providing high-quality drugs. Amphastar Pharmaceuticals ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Employees Details

Examining Amphastar Pharmaceuticals's Employee Base

Amphastar Pharmaceuticals's employees are a pivotal aspect of its operations, driving innovation, productivity, and growth. The size and composition of the workforce offer insights into the company's scale, diversity, and investment in human capital. Analyzing employee trends and data is essential for understanding Amphastar Pharmaceuticals's operational capacity and future potential.

Year-to-Year Comparison

Assessing Amphastar Pharmaceuticals's employee numbers year-over-year helps in identifying growth patterns, expansions, or contractions. An increasing employee count can indicate scaling operations and investment in talent, while a decrease may signal efficiency improvements, automation, or business challenges.

Impact on Investments

Amphastar Pharmaceuticals's employee data impacts investment decisions by shedding light on the company’s operational efficiency, innovation capability, and sustainability. Investors assess workforce data to gauge the firm's potential to execute strategies, innovate, and adapt to market changes effectively.

Interpreting Employee Trends

Fluctuations in Amphastar Pharmaceuticals’s employee numbers indicate changes in business strategy, operational demands, and market dynamics. Investors and analysts scrutinize these trends to evaluate the company’s strategic positioning, adaptability, and potential for sustainable growth.

Frequently Asked Questions about Amphastar Pharmaceuticals stock

How many employees does Amphastar Pharmaceuticals have this year?

Amphastar Pharmaceuticals has 1,980 undefined employees this year.

How many employees did Amphastar Pharmaceuticals have compared to the previous year?

Compared to the previous year, Amphastar Pharmaceuticals had 0% more employees.

What impact did the number of employees have on the company Amphastar Pharmaceuticals?

The number of employees has a direct impact on the efficiency and productivity of Amphastar Pharmaceuticals. A higher number of employees can indicate that the company is growing and has more resources to achieve its goals, while a lower number of employees may suggest that the company is saving costs or facing difficulties in recruiting new employees.

What impact did the number of employees have on investors of Amphastar Pharmaceuticals?

The number of employees can also have an impact on investors of Amphastar Pharmaceuticals, as it can be an indicator of the company's growth and financial health. A higher number of employees can promise investors, while a lower number of employees may raise concerns.

How does an increase in equity capital of Amphastar Pharmaceuticals affect the company?

An increase in equity of Amphastar Pharmaceuticals can improve the financial strength of the company and increase its ability to make future investments and fulfill obligations.

How does a reduction in Amphastar Pharmaceuticals's equity affect the company?

A reduction in equity of Amphastar Pharmaceuticals can impair its financial stability and decrease its ability to fulfill future investments and obligations.

What are some factors that influence the equity of Amphastar Pharmaceuticals?

Some factors that can influence the equity of Amphastar Pharmaceuticals include, among others, revenue development, profit and loss statement, dividend payments, and investments.

Why is the equity of Amphastar Pharmaceuticals so important for investors?

The equity of Amphastar Pharmaceuticals is important for investors as it is an indicator of the company's financial stability and provides investors with information on the amount of financial backing the company has in terms of obligations and future investments.

How does the number of employees at Amphastar Pharmaceuticals influence the company?

The number of employees at Amphastar Pharmaceuticals can directly impact the growth and performance of the company. A higher number of employees can lead to increased capacity and productivity, while a lower number of employees may result in reduced efficiency and limitations.

How has the number of employees at Amphastar Pharmaceuticals evolved in recent years?

In recent years, the number of employees at Amphastar Pharmaceuticals has changed by 0.

How many employees does Amphastar Pharmaceuticals currently have?

Amphastar Pharmaceuticals currently has 1,980 undefined employees.

Why is the number of employees important for investors of Amphastar Pharmaceuticals?

The number of employees is important for investors of Amphastar Pharmaceuticals as it is an indicator of the growth potential and performance of the company. It also provides information on how the company is able to manage and recruit its workforce.

What strategic measures can Amphastar Pharmaceuticals take to change the number of employees?

To change the number of employees, Amphastar Pharmaceuticals can take various measures such as adjusting compensation packages, improving working conditions, conducting recruitment campaigns, and promoting a positive corporate culture. It is important for the company to conduct a thorough assessment of its situation to determine the best strategic actions to change its number of employees.

How much dividend does Amphastar Pharmaceuticals pay?

Over the past 12 months, Amphastar Pharmaceuticals paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Amphastar Pharmaceuticals is expected to pay a dividend of 0 USD.

What is the dividend yield of Amphastar Pharmaceuticals?

The current dividend yield of Amphastar Pharmaceuticals is .

When does Amphastar Pharmaceuticals pay dividends?

Amphastar Pharmaceuticals pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Amphastar Pharmaceuticals?

Amphastar Pharmaceuticals paid dividends every year for the past 0 years.

What is the dividend of Amphastar Pharmaceuticals?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Amphastar Pharmaceuticals located?

Amphastar Pharmaceuticals is assigned to the 'Health' sector.

Wann musste ich die Aktien von Amphastar Pharmaceuticals kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Amphastar Pharmaceuticals from 10/4/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 10/4/2024.

When did Amphastar Pharmaceuticals pay the last dividend?

The last dividend was paid out on 10/4/2024.

What was the dividend of Amphastar Pharmaceuticals in the year 2023?

In the year 2023, Amphastar Pharmaceuticals distributed 0 USD as dividends.

In which currency does Amphastar Pharmaceuticals pay out the dividend?

The dividends of Amphastar Pharmaceuticals are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Amphastar Pharmaceuticals

Our stock analysis for Amphastar Pharmaceuticals Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Amphastar Pharmaceuticals Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.